These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10715250)

  • 21. Comparison of usefulness of each of five predictors of mortality and urgent transplantation in patients with advanced heart failure.
    Sachdeva A; Horwich TB; Fonarow GC
    Am J Cardiol; 2010 Sep; 106(6):830-5. PubMed ID: 20816124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peak VO2 in elderly patients with heart failure.
    Lund LH; Mancini DM
    Int J Cardiol; 2008 Apr; 125(2):166-71. PubMed ID: 18067981
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of time past exercise testing on prognostic variables in heart failure.
    Arena R; Myers J; Aslam SS; Varughese EB; Peberdy MA
    Int J Cardiol; 2006 Jan; 106(1):88-94. PubMed ID: 16046013
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of changes over time in exercise capacity and echocardiographic measurements in patients with chronic heart failure.
    Florea VG; Henein MY; Anker SD; Francis DP; Chambers JS; Ponikowski P; Coats AJ
    Eur Heart J; 2000 Jan; 21(2):146-53. PubMed ID: 10637088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Severe heart failure prognosis evaluation for transplant selection in the era of beta-blockers: role of peak oxygen consumption.
    Cattadori G; Agostoni P; Corrà U; Di Lenarda A; Sinagra G; Veglia F; Salvioni E; La Gioia R; Scardovi AB; Emdin M; Metra M; Limongelli G; Raimondo R; Re F; Guazzi M; Belardinelli R; Parati G; Magrì D; Fiorentini C; Mezzani A; Scrutinio D; Pacileo G; Apostolo A; Iorio A; Paolillo S; Palermo P; Contini M; Giannuzzi P; Battaia E; Cicoira M; Passino C; Piepoli MF;
    Int J Cardiol; 2013 Oct; 168(5):5078-81. PubMed ID: 23962781
    [No Abstract]   [Full Text] [Related]  

  • 26. Impact of exercise testing mode on exercise parameters in patients with chronic heart failure.
    Beckers PJ; Possemiers NM; Van Craenenbroeck EM; Van Berendoncks AM; Wuyts K; Vrints CJ; Conraads VM
    Eur J Prev Cardiol; 2012 Jun; 19(3):389-95. PubMed ID: 21450577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic Value of Cardiopulmonary Exercise Testing in Heart Failure With Reduced, Midrange, and Preserved Ejection Fraction.
    Nadruz W; West E; Sengeløv M; Santos M; Groarke JD; Forman DE; Claggett B; Skali H; Shah AM
    J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29089342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of the oxygen uptake efficiency slope: percent-predicted versus actual value.
    Arena R; Myers J; Abella J; Pinkstaff S; Brubaker P; Kitzman D; Peberdy MA; Bensimhon D; Chase P; Guazzi M
    Am J Cardiol; 2010 Mar; 105(5):757-8. PubMed ID: 20185029
    [No Abstract]   [Full Text] [Related]  

  • 29. The metabolic exercise test data combined with Cardiac And Kidney Indexes (MECKI) score and prognosis in heart failure. A validation study.
    Corrà U; Agostoni P; Giordano A; Cattadori G; Battaia E; La Gioia R; Scardovi AB; Emdin M; Metra M; Sinagra G; Limongelli G; Raimondo R; Re F; Guazzi M; Belardinelli R; Parati G; Magrì D; Fiorentini C; Cicoira M; Salvioni E; Giovannardi M; Veglia F; Mezzani A; Scrutinio D; Di Lenarda A; Ricci R; Apostolo A; Iorio AM; Paolillo S; Palermo P; Contini M; Vassanelli C; Passino C; Giannuzzi P; Piepoli MF; ; ; Antonioli L; Segurini C; Bertella E; Farina S; Bovis F; Pietrucci F; Malfatto G; Roselli T; Buono A; Calabrò R; De Maria R; Santoro D; Campanale S; Caputo D; Bertipaglia D; Berton E
    Int J Cardiol; 2016 Jan; 203():1067-72. PubMed ID: 26638056
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RE: "Is there a difference between patients with peak oxygen consumption below 10 ml/kg/min versus between 10 and 14 ml/kg/min? Does the "grey zone" really exist?".
    Lund LH; Mancini DM
    Transplant Proc; 2011 Mar; 43(2):666-7. PubMed ID: 21440790
    [No Abstract]   [Full Text] [Related]  

  • 31. Peak exercise oxygen pulse and prognosis in chronic heart failure.
    Lavie CJ; Milani RV; Mehra MR
    Am J Cardiol; 2004 Mar; 93(5):588-93. PubMed ID: 14996584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of age on aerobic capacity in heart failure patients under beta-blocker therapy: possible impact in clinical decision-making?
    Ciolac EG; Bocchi EA; Fernandes da Silva MM; Tavares AC; Teixeira-Neto IS; Guimarães GV
    Cardiol J; 2013; 20(6):655-61. PubMed ID: 24338544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiopulmonary exercise testing for prognosis in chronic heart failure: continuous and independent prognostic value from VE/VCO(2)slope and peak VO(2).
    Francis DP; Shamim W; Davies LC; Piepoli MF; Ponikowski P; Anker SD; Coats AJ
    Eur Heart J; 2000 Jan; 21(2):154-61. PubMed ID: 10637089
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heart failure prognosis over time: how the prognostic role of oxygen consumption and ventilatory efficiency during exercise has changed in the last 20 years.
    Paolillo S; Veglia F; Salvioni E; Corrà U; Piepoli M; Lagioia R; Limongelli G; Sinagra G; Cattadori G; Scardovi AB; Metra M; Senni M; Bonomi A; Scrutinio D; Raimondo R; Emdin M; Magrì D; Parati G; Re F; Cicoira M; Minà C; Correale M; Frigerio M; Bussotti M; Battaia E; Guazzi M; Badagliacca R; Di Lenarda A; Maggioni A; Passino C; Sciomer S; Pacileo G; Mapelli M; Vignati C; Clemenza F; Binno S; Lombardi C; Filardi PP; Agostoni P;
    Eur J Heart Fail; 2019 Feb; 21(2):208-217. PubMed ID: 30632680
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug and device effects on peak oxygen consumption, 6-minute walk distance, and natriuretic peptides as predictors of therapeutic effects on mortality in patients with heart failure and reduced ejection fraction.
    Wessler BS; Kramer DG; Kelly JL; Trikalinos TA; Kent DM; Konstam MA; Udelson JE
    Circ Heart Fail; 2011 Sep; 4(5):578-88. PubMed ID: 21705485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validation of peak exercise oxygen consumption and the Heart Failure Survival Score for serial risk stratification in advanced heart failure.
    Lund LH; Aaronson KD; Mancini DM
    Am J Cardiol; 2005 Mar; 95(6):734-41. PubMed ID: 15757599
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incremental value of N-terminal pro-brain natriuretic peptide over left ventricle ejection fraction and aerobic capacity for estimating prognosis in heart failure patients.
    Kallistratos MS; Dritsas A; Laoutaris ID; Cokkinos DV
    J Heart Lung Transplant; 2008 Nov; 27(11):1251-6. PubMed ID: 18971099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiopulmonary exercise testing as prognostic indicators: Comparisons among heart failure patients with reduced, mid-range and preserved ejection fraction.
    Sato T; Yoshihisa A; Kanno Y; Suzuki S; Yamaki T; Sugimoto K; Kunii H; Nakazato K; Suzuki H; Saitoh SI; Ishida T; Takeishi Y
    Eur J Prev Cardiol; 2017 Dec; 24(18):1979-1987. PubMed ID: 29086584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. B-type natriuretic peptide and peak exercise oxygen consumption provide independent information for risk stratification in patients with stable congestive heart failure.
    de Groote P; Dagorn J; Soudan B; Lamblin N; McFadden E; Bauters C
    J Am Coll Cardiol; 2004 May; 43(9):1584-9. PubMed ID: 15120815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peak oxygen consumption and heart failure prognosis in women.
    Lavie CJ; Milani RV; Ventura HO; Mehra MR
    J Am Coll Cardiol; 2007 Jan; 49(3):375; author reply 375-6. PubMed ID: 17239721
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.